PAM
ARRY

Princeton Alpha Management’s Array Biopharma Inc ARRY Stock Holding History

Princeton Alpha Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-42,193
Closed -$285K – 951
2016
Q3 		$285K Buy
+42,193
New +$163K 0.05% 517
2015
Q3 		– Sell
-10,413
Closed -$75K – 988
2015
Q2 		$75K Buy
+10,413
New +$76.8K 0.01% 668
2015
Q1 		– Sell
-25,785
Closed -$122K – 949
2014
Q4 		$122K Buy
+25,785
New +$102K 0.03% 620
2014
Q3 		– Sell
-20,325
Closed -$93K – 896
2014
Q2 		$93K Buy
+20,325
New +$84.1K 0.02% 639

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Princeton Alpha Management's ARRY Position: Q4 2016 in Review

Princeton Alpha Management sold out of Array Biopharma Inc (ARRY) in Q4 2016, closing a stake of 42,193 shares — an estimated $285K sold.

Princeton Alpha Management first reported a position in ARRY in Q2 2014 and held it in 4 quarters. The position peaked at $285K in Q3 2016. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • Princeton Alpha Management reported no remaining Array Biopharma Inc position as of Q4 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 42,193 Array Biopharma Inc shares in Q4 2016, an estimated $285K.
  • Princeton Alpha Management first reported a position in Array Biopharma Inc in Q2 2014 and held it in 4 quarters.
  • Princeton Alpha Management's Array Biopharma Inc position peaked at $285K in Q3 2016.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.